IceCure Medical Ltd Stock Forecast for 2023 - 2025 - 2030

Updated on 05/02/2024

Stock Rating
9
Price Target
$3.00
Consensus
Outperform
Upside
156.41%
Analysts
3
Stock Rating
9
Upside
156.41%
Analysts
3
Price Target
$3.00

IceCure Medical Ltd Stock Forecast and Price Target

IceCure Medical Ltd's stock price reaches the average target of $3.00 by 2025 as expected recently by three notable experts, there would be a potential upside of approximately 156.41% from the last closing price in May, 2024. This possible increase is based on a high estimate of $3.00 and a low estimate of $3.00.

$3.00

156.41% Upside

Outperform
Outperform

IceCure Medical Ltd Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, IceCure Medical Ltd's Price has grown by 100.00%, from $0.00 to $0.00. For the next year, analysts are expecting Fair Value to reach $0.00 – an increase of 100.00%. Over the next six years, experts predict that Fair Value will grow by 100.00%.

2025 Fair Value Forecast
$0.00
2026 Fair Value Forecast
$0.00
2027 Fair Value Forecast
$0.00
2028 Fair Value Forecast
$0.00
2029 Fair Value Forecast
$0.00
2030 Fair Value Forecast
$0.00

IceCure Medical Ltd Revenue Forecast for 2023 - 2025 - 2030

In the last two years, IceCure Medical Ltd's Revenue has gone down from $13.13M to $3.09M – a 76.47% drop. For the next year, analysts are expecting Revenue to reach $6.03M – an increase of 95.04%. Over the next eight years, experts predict that Revenue will grow by 140.54%.

2023 Rev Forecast
$0.01B
2024 Rev Forecast
$0.01B
2025 Rev Forecast
$0.01B
2026 Rev Forecast
$0.01B
2027 Rev Forecast
$0.01B
2028 Rev Forecast
$0.01B
2029 Rev Forecast
$0.01B
2030 Rev Forecast
$0.01B

IceCure Medical Ltd Dividend per Share Forecast for 2023 - 2025 - 2030

IceCure Medical Ltd Free Cash Flow Forecast for 2023 - 2025 - 2030

IceCure Medical Ltd EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, IceCure Medical Ltd's EBITDA has grown by 19.58%, rising from $-13.79M to $-16.49M. 0 analysts predict IceCure Medical Ltd's EBITDA will decrease by 13.30% in the next year, reaching $-14.30M. By 2030, professionals predict that IceCure Medical Ltd's EBITDA will decrease by 12.81%, to $-14.38M.

2023 EBITDA Forecast
$-14296280.33
2024 EBITDA Forecast
$-15116410.28
2025 EBITDA Forecast
$-13510543.63
2026 EBITDA Forecast
$-14492309.80
2027 EBITDA Forecast
$-14477334.41
2028 EBITDA Forecast
$-14729240.03
2029 EBITDA Forecast
$-14317803.26
2030 EBITDA Forecast
$-14377938.03

IceCure Medical Ltd EBIT Forecast for 2023 - 2025 - 2030

In the last two years, IceCure Medical Ltd's EBIT has grown, rising from $-14.03M to $-16.74M – a growth of 19.32%. For the following year, the 0 analysts predict that IceCure Medical Ltd's EBIT will drop by 13.18%, reaching $-14.53M. In 2030, the professionals' prediction is that ICCM's EBIT will decrease by 12.71%, reaching $-14.61M.

2023 EBIT Forecast
$-14533668.00
2024 EBIT Forecast
$-15385340.94
2025 EBIT Forecast
$-13728852.57
2026 EBIT Forecast
$-14722363.87
2027 EBIT Forecast
$-14711567.47
2028 EBIT Forecast
$-14975885.30
2029 EBIT Forecast
$-14554563.72
2030 EBIT Forecast
$-14612781.98

IceCure Medical Ltd EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, IceCure Medical Ltd's EPS has grown by 100.00%, from $-0.35 to $0.00. For the next year, analysts are expecting EPS to reach $0.00 – an increase of 100.00%. Over the next six years, experts predict that EPS will grow by 100.00%.

2025 EPS Forecast
$0.00
2026 EPS Forecast
$0.00
2027 EPS Forecast
$0.00
2028 EPS Forecast
$0.00
2029 EPS Forecast
$0.00
2030 EPS Forecast
$0.00